Cargando…
Myeloid Cells in Glioblastoma Microenvironment
Glioblastoma (GBM) is the most aggressive, malignant primary brain tumor in adults. GBM is notoriously resistant to immunotherapy mainly due to its unique immune microenvironment. High dimensional data analysis reveals the extensive heterogeneity of immune components making up the GBM microenvironme...
Autores principales: | De Leo, Alessandra, Ugolini, Alessio, Veglia, Filippo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824606/ https://www.ncbi.nlm.nih.gov/pubmed/33374253 http://dx.doi.org/10.3390/cells10010018 |
Ejemplares similares
-
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
por: Veglia, Filippo, et al.
Publicado: (2021) -
Immunohistochemical Characterization of Immune Infiltrate in Tumor Microenvironment of Glioblastoma
por: Rahimi Koshkaki, Hassan, et al.
Publicado: (2020) -
Targeting the TREM1-positive myeloid microenvironment in glioblastoma
por: Filippova, Natalia, et al.
Publicado: (2022) -
T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10
por: Ravi, Vidhya M., et al.
Publicado: (2022) -
Erratum to: Targeting the TREM1-positive myeloid microenvironment in glioblastoma
Publicado: (2023)